Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04011592 · ClinicalTrials.gov registry record · Phase 2
Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT04011592 is a Phase 2 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1 participants.
The verdict
NCT04011592, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
Postpartum depression is a non-psychotic major or minor depressive episode that occurs during pregnancy or within 12 months of post-partum period. The nature of symptoms is same as depressive episode characterized by depressed mood, anxiety, sleep difficulties, suicidal thoughts, tiredness and diminished interest in pleasurable activities. Severe maternal depression affects children by increasing the risk of emotional and behavioral and physical health problems and cognitive difficulties. Thus early screening and intervention is critical in reducing the negative impact of PND in the mother and child, family and the community. The purpose of this study is to assess the safety, pharmacokinetics and antidepressant efficacy of sub-anesthetic dose of intravenous ketamine in perinatal depression.
Interventions
- DRUG Ketamine 0.5 mg/kg
- DRUG Ketamine 0.2 mg/kg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2019-09-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04011592
The ClinicalTrials.gov registry entry for NCT04011592 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine 0.5 mg/kg is the first listed.
NCT04011592 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04011592 about?
NCT04011592 is a clinical study titled "Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression". Postpartum depression is a non-psychotic major or minor depressive episode that occurs during pregnancy or within 12 months of post-partum period. The nature of symptoms is same as depressive episode characterized by depressed mood, anxiety, sleep difficulties, suicidal thoughts, tiredness and dimin...
What is the current status of trial NCT04011592?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2019-03-04. Estimated completion is 2019-09-09.
What interventions are being tested in trial NCT04011592?
The interventions under investigation include: Ketamine 0.5 mg/kg (DRUG), Ketamine 0.2 mg/kg (DRUG).
Who is sponsoring clinical trial NCT04011592?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.